Navigation Links
Nektar Receives Patent Covering Pulmonary Targeted Antibiotics
Date:5/7/2008

U.S. Patent Encompassing Tobramycin Inhalation Powder and Other

Aminoglycoside Antibiotics Issued to Nektar

SAN CARLOS, Calif., May 7 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Patent and Trademark Office has issued Patent No. 7,368,102, which covers compositions and methods for creating and delivering Tobramycin Inhalation Powder (TIP) and other aminoglycoside antibiotics delivered via Nektar's proprietary Dry Powder Inhaled Technology. This patent extends through the year 2022.

TIP is being co-developed by Nektar and Novartis and is currently in Phase 3 development for the prevention and treatment of Pseudomonas aeruginosa pneumonia. Cystic fibrosis patients are susceptible to chronic infection by P. aeruginosa, which is responsible for high rates of illness and death in this patient population. Nektar's Dry Powder Inhaled Technology has the capability to administer high local lung concentrations of TIP that may provide significant benefits to patients suffering from this debilitating disease.

"Issuance of this patent further demonstrates the power of Nektar's pulmonary technology platform, as well as our industry leadership in the emerging field of targeted anti-infective therapeutics," said Nektar President and Chief Executive officer, Howard W. Robin. "Nektar will continue to aggressively file patents to ensure that the company remains at the forefront of our fields."

About Cystic Fibrosis

Cystic fibrosis (CF) is a genetic disease. About 30,000 people in the United States and about 70,000 people worldwide have CF. Patients with CF have abnormal movement of salt in and out of the cells lining their lungs, which leads to secretion of
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets
2. West Concludes Agreement with Nektar
3. Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
4. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
5. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
6. Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
7. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
8. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
9. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... have succeeded in measuring vibrational motion of a single ... how vibration of a single molecule differs from the ... was performed at the University of California, Irvine, where ... works as a visiting fellow under professor Vartkess A. ... team was lead by Professor Eric O. Potma. The ...
(Date:8/20/2014)... Group finds that the vascular access device market in ... and China (BRIC) was valued ... of the United States market that year. ... as a result of strong economic expansion, improving access to healthcare ... Resources Group,s coverage of the BRIC vascular access device market: ...
(Date:8/20/2014)... 20, 2014 Not long ago, it ... should be performed late in the development cycle – ... current regulatory trends suggest that, like many things GxP, ... In recent years, multiple drug sponsors have been required ... specific questions during phase I/II. It’s not only clinical ...
(Date:8/20/2014)... WriteResult®, a leading provider of Electronic ... expanded its myPROpad™ ePRO tablet with the addition of ... the most widely used and well-respected Patient Reported Outcome ... EQ-5D is used during clinical trials and in other ... be used to demonstrate Health-Related Quality of Life outcomes ...
Breaking Biology Technology:Seeing a molecule breathe 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2EQ-5D™ Assessment Now Available for iPad 2
... , , , , Multiporator , , , , , ... Transfection Protocol , Protocol No. 4308 915.040 11/2000 , ... , , , Cell line , ... Transfection with , Plasmid pEGFP-C1 (in bidistilled H 2 O), ...
... , , , Multiporator / Electroporator 2510 , , , , , ... Transformation Protocol , Protocol No. 4308 915.531 12/2001 , ... , , , Microorganism ... Cell type , Yeast, ...
... , , , , , , , Multiporator / Electroporator 2510 , ... , Transformation Protocol , Protocol ... , , , , , ... , , Cell type , ...
Cached Biology Technology:U-266 2Saccharomyces cerevisiae 2Staphylococcus aureus 2
(Date:8/19/2014)... 2014 ) -- Scientists at the Houston Methodist Research ... transfer single cells using a pipette -- a common ... engineering feat and preliminary test results in a recent ... Society . , "Studying single cells and their unique ... said nanomedicine department. faculty member Lidong Qin, Ph.D., the ...
(Date:8/19/2014)... Science Center at San Antonio and The University of ... of more than $750,000 in grants through the San ... in 2003, SALSI is a model of how a ... center join forces for greater research and graduate education. ... focus on public health issues and diseases of global ...
(Date:8/19/2014)... at the University of Liverpool has found how worms ... with the body. , Dr Paolo Paoletti, alongside his ... mathematical model for earthworms and insect larvae which challenges ... get around. , The most widely accepted model is ... that the central brain of these creatures generates rhythmic ...
Breaking Biology News(10 mins):Moving single cells around -- accurately and cheaply 2San Antonio Life Sciences Institute awards $750,000 to innovators 2San Antonio Life Sciences Institute awards $750,000 to innovators 3Secrets of how worms wriggle uncovered 2
... by researchers at Cardiff University is opening up new possibilities ... unnatural materials such as metal ions into cells, a process ... disciplines. One technique currently used is called the ,Trojan Horse, ... something naturally taken up by cells. The Cardiff ...
... is available in Spanish . A study ... University Hospital San Cecilio revealed that preterm mothers, milk contains low ... importance, due both to its antioxidant capacity and to its role ... This study counted with the participation of a group of ...
... even zoo gorillas need to switch to a heart-healthy diet. ... said Elena Hoellein Less, a PhD candidate in biology at Case ... number one killer of male Western lowland gorillas the only ... a 21-year-old gorilla, died of heart failure at Cleveland Metroparks Zoo ...
Cached Biology News:Sleeping Trojan horse to aid imaging of diseased cells 2Preterm mothers' milk contains less antioxidants than mothers completing their gestation 2Apes shed pounds while doubling calories, CWRU researcher finds 2Apes shed pounds while doubling calories, CWRU researcher finds 3
... unique combination of Coulter volume and ... and accurate cell counting. This flow ... UV, allowing flexible fluorochrome selection for ... only achievable with larger, more expensive ...
... novel procedure for the uniform amplification and ... DNA from small samples. This method has ... highly reproducible amplification and labeling procedure for ... Mini Kit module (QIAGEN) and a ULS ...
... Protein/antibody delivery using PULSin may be ... For example, unlike traditional transfection, with PULSin ... the level and time course of proteins ... may provide more information than traditional RNA ...
... is an innovative reagent for highly efficient ... of living cells. Unlike DNA transfection, with ... amount and timing of exogenous proteins in ... can now be studied. Real time ...
Biology Products: